Equities

Bright Green Corp

BGXX:PKC

Bright Green Corp

Actions
  • Price (USD)0.0367
  • Today's Change-0.036 / -49.45%
  • Shares traded3.69m
  • 1 Year change-90.46%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

  • Revenue in USD (TTM)0.00
  • Net income in USD-9.92m
  • Incorporated2019
  • Employees5.00
  • Location
    Bright Green Corp401 East Las Olas Blvd., Suite 1400FT LAUDERDALE 33301United StatesUSA
  • Phone+1 (201) 370-1140
  • Fax+1 (302) 636-5454
  • Websitehttps://brightgreen.us/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BGXX:PKC since
announced
Transaction
value
C2 Wellness CorpAnnounced25 Jan 202425 Jan 2024Announced-84.71%1.20m
Data delayed at least 15 minutes, as of Sep 20 2024 21:03 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Silo Pharma Inc72.12k-3.45m4.66m3.00--0.6495--64.67-1.16-1.180.02421.600.0079----24,040.00-37.69-24.90-43.50-26.3991.9082.79-4,777.02-2,757.85----0.00--0.00--7.07------
Stemtech Corp5.37m-5.11m4.83m45.00------0.8998-0.0518-0.05180.0529-0.03591.338.3942.31---126.26------77.87---95.16--0.065-2.59----7.94--36.45------
CYANOTECH CORP23.82m-5.10m4.87m77.00--0.4563--0.2045-0.7549-0.75493.561.530.88952.0512.12309,389.60-19.04-3.46-29.60-4.4624.7234.54-21.41-3.580.3354-6.610.377---0.4616-5.24-53.11---6.42--
AgriFORCE Growing Systems Ltd57.60k-15.05m5.16m7.00--0.4074--89.59-5.81-5.810.00370.13430.0034--1.218,228.57-88.79-78.95-124.14-109.8617.86---26,121.49-243,182.501.24-1.280.0789------8.85--48.61--
Titan Pharmaceuticals Inc4.00k-5.46m5.17m4.00--1.30--1,293.64-6.59-6.590.00494.370.0016--0.17021,000.00-211.58-96.80-368.99-156.65-----136,525.00-406.26---309.960.00---66.97-51.1645.43---65.61--
Sonnet Biotherapeutics Holdings Inc55.89k-7.99m5.20m12.00--1.99--93.08-3.02-3.020.01440.50170.0071--0.08814,657.50-100.88---255.30-------14,287.67-----331.070.00---57.76--36.64------
Hoth Therapeutics Inc0.00-7.46m6.70m2.00--0.5565-----1.69-1.690.001.740.00----0.00-67.99-157.07-76.33-177.32------------0.00------31.01------
Integrated BioPharma, Inc.50.57m-116.00k6.86m141.00--0.362932.370.1357-0.0041-0.00411.670.62831.884.4510.76358,617.00-0.43115.54-0.569828.007.0912.09-0.22946.451.02-9.000.001---9.913.00-100.42---14.03--
Bon Natural Life Ltd29.52m4.60m6.95m96.000.35070.05791.260.23544.994.9932.1030.230.704515.275.19307,524.6010.8614.0413.6920.6829.9430.0015.4217.622.4130.540.09550.00-1.2922.32-26.3283.09-6.70--
Universe Pharmaceuticals Inc32.31m-6.16m6.95m225.00--0.027--0.2152-1.70-1.708.9110.910.57277.932.50143,594.40-10.925.31-14.347.0731.9346.26-19.086.252.43-28.050.12180.00-19.522.5329.46---21.17--
Bright Green Corp0.00-9.92m6.98m5.00--0.7076-----0.0538-0.05380.000.05190.00----0.00-47.48---72.55--------------0.0494------52.54------
Biofrontera Inc35.24m-13.51m7.10m85.00--0.5976--0.2013-5.29-5.2912.122.141.211.977.27414,623.50-46.20---113.24--47.75---38.33--1.46-3.530.0264--18.82---3,045.47------
Coeptis Therapeutics Holdings Inc0.00-16.14m7.15m5.00---------0.5143-0.51430.00-0.01110.00----0.00-284.35-37.29-709.12-38.23------------1.22------43.40------
CV Sciences Inc15.85m-2.53m8.08m42.00--3.22--0.5096-0.0157-0.01570.0980.01391.691.5525.35377,285.70-26.94-43.42-73.44-77.7546.0651.81-15.95-45.680.2530--0.0114---1.24-19.80133.96-20.87----
Data as of Sep 20 2024. Currency figures normalised to Bright Green Corp's reporting currency: US Dollar USD

Institutional shareholders

2.92%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Aug 20242.27m1.19%
Geode Capital Management LLCas of 31 Jul 20241.54m0.80%
Jane Street Capital LLCas of 30 Jun 2024611.72k0.32%
Susquehanna Financial Group LLLPas of 30 Jun 2024431.18k0.23%
Y-Intercept (Hong Kong) Ltd.as of 30 Jun 2024221.39k0.12%
Centiva Capital LPas of 30 Jun 2024134.90k0.07%
Point72 Asset Management LPas of 30 Jun 2024109.56k0.06%
BlackRock Investment Management LLCas of 30 Jun 2024100.15k0.05%
Paloma Partners Management Co.as of 30 Jun 202478.76k0.04%
Qube Research & Technologies Ltd.as of 30 Jun 202474.64k0.04%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.